← Eichor
Condition: Polycythemia Vera Pv Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Polycythemia Vera Pv

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

MPN PROGRESSion Registry: Observational Study Tracking Symptoms, Treatments, and Disease Progression in People With Myel
Phase N/A · 2 location(s) · MPN Research Foundation · NCT07362225A Phase 1 Study of PRT12396 in Participants With Select Myeloproliferative Neoplasms
Phase 1 · 5 location(s) · Prelude Therapeutics · NCT07469891A Phase 2, Open-Label Study of DISC-3405 in Participants With Polycythemia Vera (PV)
Phase 2 · 15 location(s) · Disc Medicine, Inc · NCT06985147Ropeginterferon Alfa-2b in Patients With Polycythemia Vera (PV) Without Symptomatic Splenomegaly
Phase N/A · 1 location(s) · iOMEDICO AG · NCT06743035Pegylated Interferon α-2b in Combination With Ruxolitinib for Treating Hydroxyurea-resistant/Intolerant PV
Phase 2 · 1 location(s) · Institute of Hematology & Blood Diseases Hospital, China · NCT05870475Observational Study on the Use of Ropeginterferon Alfa-2b in Polycythemia Vera (ROPEG-PV)
Phase N/A · 37 location(s) · FROM- Fondazione per la Ricerca Ospedale di Bergamo- ETS · NCT06506084MethoTRExATE in MyelOpRolifErative Neoplasms (TREATMORE) Trial
Phase 2 · 1 location(s) · Icahn School of Medicine at Mount Sinai · NCT06541249Study on Efficacy and Safety of Givinostat Versus Hydroxyurea in Patients With Polycythemia Vera
Phase 3 · 90 location(s) · Italfarmaco · NCT06093672INTREPID: A Study of Sapablursen Evaluating the Safety and Efficacy in Participants With Polycythemia Vera (PV)
Phase 3 · 6 location(s) · Ono Pharmaceutical Co., Ltd. · NCT07429266Study of Pelabresib add-on to Ruxolitinib in Japanese Adult Patients With Myelofibrosis
Phase 1 · 7 location(s) · Novartis Pharmaceuticals · NCT07340138Extension Study of P1101 After Completion of Phase 2 Study in PV Patients or Phase 3 Study in ET Patients
Phase 3 · 6 location(s) · PharmaEssentia Japan K.K. · NCT04655092A Clinical Study of Gecacitinib Combined With Pegylated Interferon in Patients With PV
NA · 1 location(s) · Duan Minghui · NCT07445893Efficacy and Safety of Peginterferon in ET and PV.
NA · 1 location(s) · Zhenya Hong · NCT06734637Reparixin in Patients With Myelofibrosis Myeloproliferative Neoplasms Research Consortium (MPN-RC 120)
Phase 2 · 9 location(s) · Icahn School of Medicine at Mount Sinai · NCT05835466Open Label Phase 1/2 Study of Tasquinimod in Patients With Primary Myelofibrosis (PMF), Post-Polycythemia Vera Myelofibr
Phase 1/Phase 2 · 1 location(s) · M.D. Anderson Cancer Center · NCT06327100Phase IIa Study on Flonoltinib Maleate Tablets in the Treatment of Patients With Polycythemia Vera
Phase 2 · 1 location(s) · Chengdu Zenitar Biomedical Technology Co., Ltd · NCT07232290
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.